I also don't see an exclusion based on diagnosis? I see that portions of the normative sample had histories of psychiatric hospitalization as well as past and current mental health treatment. And then the various clinical samples, including individuals across settings reporting a history of antipsychotic medication use. But I could be missing something.
Also, most of the scales--and especially the restructured clinical scales--remained largely unchanged from the MMPI-2-RF to the MMPI-3 and research on those scales go back to the MMPI-2 era.
The claim that the MMPI-3 lacks valid normative data to yield meaningful or valid interpretations in contexts of testing patients with psychotic disorders is a pretty bold claim. I'm not going to dismiss it outright and we surely need to look into it. It would be one of the most monumental scientific scandals in all of psychological assessment history if true. I know that it has widespread forensic use and courtrooms are usually, at least over a good period of time, pretty effective at rooting out such obvious tomfoolery or scandal on the part of highly-paid expert witnesses and consultants.
I know there's a 'defending MMPI-3' testimony article (e.g., examining the Daubert standard, etc.) as well as one for the MMPI-2-RF floating around the forensic psych literature. Maybe someone more expert at the psychometric underpinnings of the MMPI-3 or who is a forensic psychologist who uses it routinely could chime in.
Alternatively, if someone would like to chime in with a citation to a piece of published work that makes a substantive and well-reasoned argument that the MMPI-3 lacks appropriate normative data to allow it to be used effectively to address psychotic spectrum disorders or populations with such diagnoses, I'm all ears.
I think it's also important to consider the fact that (if I understand things correctly) the MMPI-2-RF and MMPI-3 reflect changes in how the field is viewing psychopathology (including psychosis or unusual bizarre thinking styles or patterns) these days as more of a continuum rather than a dichotomy. I know that some of the materials used for interpreting, say, elevations on the thought disorder scales of the MMPI-2-RF emphasize that fact. The MMPI-2-RF (and MMPI-3) scales that tap into dimensions of aberrant thinking or 'thought disorder' are not supposed to be some sort of 'test' for a psychotic disorder/condition, per se (e.g., above this t-score cutoff, looks like they have schizophrenia). They are supposed to be a measure of how much of that variable appears present or relevant in that individual patient's case (as a dimensional construct) and this is merely one piece of info to be utilized as part of a multi-method approach to psychological assesment and diagnosis. Obviously, when we're talking about diagnosing specific psychotic disorders, information from direct observation, interview (especially around psychotic symptoms), chart review and other sources of info (collateral informants) becomes paramount.
If I took the approach of just naively thinking that significantly elevated THD, PSYC-r, RC6, RC8 or such scales on the MMPI-2-RF meant clear indicators of a psychotic disorder (schizophrenia, schizoaffective d/o, etc.) that was currently unmedicated and out of control exhibiting florid psychosis then more than half of the veterans I give MMPI-2-RF feedback to would end up going immediately to the inpatient unit after the feedback session.
That being said, we are DEFINITELY in need of more empirical data on contrasting the following three groups (a) patients with validated psychotic disorders diagnosed after a structured interview (e.g., SCID-5) vs. (b) veterans presenting for disability evaluation for PTSD (or veterans presenting to BHIP/ PCT clinics at the VA) vs. (c) veterans with confirmed PTSD after 'passing' embedded validity scales on the MMPI-3 (i.e., no significantly elevated F or F-p) and who have PTSD as per the CAPS-5 results and clinical interview.
We REALLY need a critical compare and contrast between / among those three specific groups in relation to normative data on how they all elevate (or fail to elevate) THD, PSYC-r, RC6, or RC8 on that instrument.
Now THAT is a critique I could get behind of the MMPI-3 scales based on my own extensive first hand experience with its cousin (the MMPI-2-RF). Unfortunately, the VA is too cheap / bureaucratic to update its access to the MMPI-3 for its clinicians at the present time.